Bowel cancer breakthrough as new drug could triple survival chance in patients

Pembrolizumab boosts the immune system’s ability to attack cancer. A study found that 59% of patients’ tumours shrank so much that there were no signs of disease when the affected section of their bowel was removed



Source link